MiNK Therapeutics, Inc.
INKT
$10.72
$0.212.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 13.36M | 14.28M | 1.68M | 3.23M | 4.58M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 276.40K | 253.10K | 274.10K | 236.20K | 246.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 211.20K | 0.00 | 55.20K | 108.70K | 164.20K |
| Total Current Assets | 13.85M | 14.53M | 2.01M | 3.58M | 4.99M |
|
|
|||||
| Total Current Assets | 13.85M | 14.53M | 2.01M | 3.58M | 4.99M |
| Net Property, Plant & Equipment | 390.90K | 429.30K | 473.20K | 687.50K | 732.90K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 14.24M | 14.96M | 2.48M | 4.27M | 5.72M |
|
|
|||||
| Total Accounts Payable | 3.43M | 3.69M | 3.31M | 2.66M | 2.73M |
| Total Accrued Expenses | 1.58M | 1.26M | 1.86M | 1.97M | 1.87M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.18M | 5.73M | 5.51M | 5.12M | -- |
| Total Finance Division Other Current Liabilities | 2.85M | 2.76M | 2.48M | 2.37M | 2.36M |
| Total Other Current Liabilities | 2.85M | 2.76M | 2.48M | 2.37M | 2.36M |
| Total Current Liabilities | 13.03M | 13.43M | 13.16M | 12.12M | 6.96M |
|
|
|||||
| Total Current Liabilities | 13.03M | 13.43M | 13.16M | 12.12M | 6.96M |
| Long-Term Debt | -- | -- | -- | -- | 4.92M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 15.44M | 15.04M | 14.51M | 13.94M | 13.42M |
| Total Liabilities | 28.47M | 28.48M | 27.67M | 26.06M | 25.31M |
|
|
|||||
| Common Stock & APIC | 143.17M | 141.25M | 126.72M | 125.82M | 125.23M |
| Retained Earnings | -156.68M | -154.07M | -151.19M | -146.95M | -144.18M |
| Treasury Stock & Other | -718.90K | -692.10K | -719.30K | -662.40K | -631.60K |
| Total Common Equity | -14.23M | -13.51M | -25.19M | -21.79M | -19.59M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -14.23M | -13.51M | -25.19M | -21.79M | -19.59M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -14.23M | -13.51M | -25.19M | -21.79M | -19.59M |
|
|
|||||